Pharmaceutical companies are turning to Contract Development and Manufacturing Organizations (CDMOs) to manufacture their products resulting in exponential growth in the contract services sector of the market. These organizations need to find process solutions to enable high quality and efficient production. Reducing risk to avoid regulatory inspections, remediation, product loss and recall are paramount. Proactive microbial detection using real-time Total Organic Carbon (TOC) and Conductivity technologies offer better process control and can mitigate the risks associated with drug development and production. Download this infographic now to learn five reasons why these technologies can help mitigate risk.